NewEdge Advisors’s HOOKIPA Pharma HOOK Stock Holding History

NewEdge Advisors’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-17	Closed	-$134	–	3744
2022 Q4	$134	Buy	+17	New	+$184	﹤0.01%	3340

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

NewEdge Advisors's HOOK Position: Q1 2023 in Review

NewEdge Advisors sold out of HOOKIPA Pharma (HOOK) in Q1 2023, closing a stake of 17 shares — an estimated $134 sold.

NewEdge Advisors first reported a position in HOOK in Q4 2022 and held it in 1 quarter. The position peaked at $134 in Q4 2022. 45 funds tracked by Wall St. Rank hold HOOK as of Q1 2023.

NewEdge Advisors reported no remaining HOOKIPA Pharma position as of Q1 2023 after selling out during the quarter.
NewEdge Advisors sold 17 HOOKIPA Pharma shares in Q1 2023, an estimated $134.
NewEdge Advisors first reported a position in HOOKIPA Pharma in Q4 2022 and held it in 1 quarter.
NewEdge Advisors's HOOKIPA Pharma position peaked at $134 in Q4 2022.
45 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q1 2023.

Based on NewEdge Advisors's 13F filing for Q1 2023, filed 12 May 2023.